相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antibodies to watch in 2014
Janice M. Reichert
MABS (2014)
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
Sandra M. Swain et al.
LANCET ONCOLOGY (2013)
Development of Copper-Catalyzed Azide-Alkyne Cycloaddition for Increased in Vivo Efficacy of Interferon β-1b by Site-Specific PEGylation
Natalie W. Nairn et al.
BIOCONJUGATE CHEMISTRY (2012)
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
Marion G. Ott et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Critical role of the interleukin-23//T-helper 17 cell axis in the pathogenesis of psoriasis
Kimiko Nakajima
JOURNAL OF DERMATOLOGY (2012)
Advances in the treatment of moderate-to-severe plaque psoriasis
Richard N. Herrier
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2011)
Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A
Karin Stenderup et al.
EXPERIMENTAL DERMATOLOGY (2011)
Long-Term Prognosis and Comorbidities Associated with Psoriasis in the Newfoundland and Labrador Founder Population
Wayne P. Gulliver et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2011)
Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry
Theo Rispens et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
Heather L. Rizzo et al.
JOURNAL OF IMMUNOLOGY (2011)
Resolution of Psoriasis by a Leukocyte-Targeting Bacterial Protein in a Humanized Mouse Model
Karin Stenderup et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Valrubicin in a Topical Formulation Treats Psoriasis in a Xenograft Transplantation Model
Cecilia Rosada et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
Shinji Kagami et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
A dual-targeting PDGFR beta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo
Robert Mabry et al.
MABS (2010)
Catumaxomab Clinical development and future directions
Rolf Linke et al.
MABS (2010)
Psoriasis: what we have learned from mouse models
Erwin F. Wagner et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Engineering of stable bispecific antibodies targeting IL-17A and IL-23
Robert Mabry et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model
K. Stenderup et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
PEG-modified biopharmaceuticals
Pascal Bailon et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators
Nazzareno Dimasi et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells
Sandrine d'Argouges et al.
LEUKEMIA RESEARCH (2009)
Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cu-catalyzed azide-alkyne cycloaddition
Morten Meldal et al.
CHEMICAL REVIEWS (2008)
Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies
Thomas K. Petersen et al.
DRUG DISCOVERY TODAY (2008)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Crystal structures of the pro-inflammatory cytokine interleukin-23 and its complex with a high-affinity neutralizing antibody
Brian M. Beyer et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
IL-21 and TGF-β are required for differentiation of human TH17 cells
Li Yang et al.
NATURE (2008)
A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T-H-17 responses
Elisabetta Volpe et al.
NATURE IMMUNOLOGY (2008)
The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt
Nicolas Manel et al.
NATURE IMMUNOLOGY (2008)
The risk of mortality in patients with psoriasis - Results from a population-based study
Joel M. Gelfand et al.
ARCHIVES OF DERMATOLOGY (2007)
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Nicholas J. Wilson et al.
NATURE IMMUNOLOGY (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
Distinct regulation of interleukin-17 in human T helper lymphocytes
Zhi Chen et al.
ARTHRITIS AND RHEUMATISM (2007)
IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis
Jason R. Chan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5 -: Effects on tumor targeting
Susanne Kubetzko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma
Sandra J. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells
MA Hoeve et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
M Mihara et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction
RS Stern et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Cell surface labeling of Escherichia coli via copper(I)-catalyzed [3+2] cycloaddition
AJ Link et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: The impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display
M Popkov et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
分享论文
